AMPK is a serine/threonine kinase that plays a central role in regulating lipid metabolism and energy homoeostasis at cellular and tissue level that makes it an attractive target for therapeutic intervention for diseases such as diabetes and obesity. Here, MARK2 is linked to obesity due to melanocortin 4 receptor deficiency.